Cargando…
Safety of human papillomavirus vaccines: a review
Introduction: Between 2006 and 2009, two different human papillomavirus virus (HPV) vaccines were licensed for use: a quadrivalent (qHPVv) and a bivalent (bHPVv) vaccine. Since 2008, HPV vaccination programmes have been implemented in the majority of the industrialized countries. Since 2013, HPV vac...
Autores principales: | Stillo, Michela, Carrillo Santisteve, Paloma, Lopalco, Pier Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667712/ https://www.ncbi.nlm.nih.gov/pubmed/25689872 http://dx.doi.org/10.1517/14740338.2015.1013532 |
Ejemplares similares
-
Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV
por: Di Mario, Simona, et al.
Publicado: (2015) -
Corrigendum to “Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV”
por: Di Mario, Simona, et al.
Publicado: (2017) -
Is EU/EEA population protected from polio?
por: Nijsten, DRE, et al.
Publicado: (2015) -
Spotlight on the 9-valent HPV vaccine
por: Lopalco, Pier Luigi
Publicado: (2016) -
Hepatitis A notifications in the EU/EEA, 2010–2019: what can we learn from case reporting to the European Surveillance System?
por: Severi, Ettore, et al.
Publicado: (2023)